UFP Technologies (UFPT) logo

UFP Technologies (UFPT) stock

Medical devices , market cap $2.3B

After-hours Fri
$291.51
+0.23%

Close $290.85 -2.70%

Quality Score
5
Below Average
In its industry
#30of 86
Checks firing
2of 14
Trending up
From 52-week high
-15.0%
under its best in a year

UFPT's Quality Score fell 3 points on Fri, Nov 20, to 5. Its price fell under its average of 8 days (3 chart checks stopped).

See UFPT's 14 chart checksSee UFPT's 14 chart checksSee it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why UFPT rose on Nov 4

Up 18% on Nov 4, an up day for the market: the S&P 500 rose 2%, 72% of stocks rose, and medical device stocks a median 7%.

“MedTech sales grew 12.5%, reflecting broad-based demand across our portfolio.”

UFP Technologies' Nov 3 release said

Sources: Price history, Nov 4, 2026; Company release, Nov 3, 2026

1 more reason, free with an account →See every reason on UFPT →3 more reasons why UFPT rose on Nov 4, from its filings, with the company's words, the timeline, and its peers, for Pro members.

Key facts on UFPT

Key facts on UFPT
The companyProfit up 14% to $77M
Latest filing10-Q, Nov 6 Filed its quarterly report (10-Q) for the quarter to Sep 30, 2026

UFPT catalysts

Coming up

After its last 4 reports it closed +13.2% on average, higher 3 of 4 times.

5 past catalysts since 2024, with sizes and sources, for Pro members.

Why UFPT scores 5

Below Averagefor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means

  • +2Chart checks 2 of 14 firing right now, one point each
  • +1Long-term trend above a rising 200-⁠day average, down over two years
  • Run-up adds
  • Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.

No effect today: Size, Growth, Dilution, Volatility, Cash flow, Persistence, News, and Insider trades.

What every line is worth, and the reason behind it, on UFPT and every other stock.Get in free →See the top 3 →Start Pro

Price, score, chart checks, and the industry rank are from a snapshot taken at 8:34 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Alert me when UFPT's Quality Score turns up

A free account. No card.Pro: $1 first month.Pro, 7 days free with a card.

How UFPT ranks in Medical Devices

UFPT is #30 of 86 by Quality Score.

How UFPT ranks in Medical Devices
RankStockQuality Score
30UFP Technologies (UFPT) logoUFPTUFP5

Net income over four quarters: UFPT $76.5M, GMED $558M, MMSI $160M, PEN $157M.

More in Medical Devices

When does UFPT report earnings, and what happens after?

Expected to report Tue Feb 23, after the close (in 94 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What UFPT reported on Nov 3, 2026

The quarter

Sales of $172.4M, 12% more than a year ago; a profit of $2.64 a share, from $2.11.

“MedTech sales grew 12.5%, reflecting broad-based demand across our portfolio.”

The quarter that ended Sep 30, from the company's press release

The press releaseThe filing on EDGAR

Where the sales came from

Where the quarter's sales came from
LineQ3
2026
Q2
2026
Q3
2025
By product
Productup 11%$169M98%$173M99%$152M98%

Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 6)

2 more lines, for Pro members.

The outlook

No outlook figures read from this release.

The numbers

Market value
$2.3B
today
Sales
$650M
up 8.6% on the year

4 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on UFPT: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

+10.3%+25.2%+17.7%
May 4Aug 3Nov 3
ReportedGapReaction5
days
Nov 3, 2026After close+9.3%+17.7%+12.0%
Aug 3, 2026After close+14.0%+25.2%+21.5%
May 4, 2026After close-5.2%+10.3%+15.3%

UFPT closed higher after 3 of its last 4 reports.

All 4 reports, and UFPT's Quality Score going into each

UFPT sales and profit by year

Sales and profit by year

Sales grew every year from 2023 to 2025, to $603M. It made a profit in each of the three years.

UFPT has 2 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on UFPT, and all 14 on every stock.Get in free →See the top 3 →Start Pro

UFPT RSI on Nov 20: 45.6, below its 50-day, above its 200-day

Not scored

RSI 45.6, MACD below signal, below its 50-day, above its 200-day. Not scored.

The deep dive on UFPT

  • What it does and how it makes money3 findingsIt kept 15 cents of each dollar of sales in fiscal 2025: $92.3M of operating profit on $603M of sales.Annual report, filed Feb 27, 2026"The expiration dates for the Company’s patents range from 2026 through 2044." (10-K for fiscal 2025)SEC filing · Feb 27, 2026
  • Where it stands2 findingsFor Pro members2 findings on where UFPT stands: its cash, debt, and share count, for Pro members
  • What changed in its filings7 findingsA new heading in its "Risk Factors" this year: "Our operating results depend in part on our ability to contain or reduce costs. There is substantial price competition in our industry and upward pressure on material and labor costs. Our success and profitability will depend on our ability to maintain a …" (10-K for fiscal 2025; not in fiscal 2024's)SEC filing · Feb 27, 2026, against the one of Mar 3, 2025Medical made up 92% of its revenue in fiscal 2025, up from 89% in fiscal 2024; another made up 22%, up from 15% in fiscal 2024.SEC filing · Feb 27, 2026
  • Who holds and trades it3 findingsFor Pro members3 findings on who holds and trades UFPT, for Pro members
  • Against its closest peers4 peersNet income over four quarters: UFPT $76.5M, GMED $558M, MMSI $160M, PEN $157M.

11 more findings on UFPT, each with its source, for Pro members.

UFPT insider trades

5 insiders sold $12.9M across 15 filings in the last 6 months. No open-⁠market buys on record. The newest:

SellMarc D. Kozin$1.1MDirectorat $303.97 on Aug 25, filed Aug 27

All 15 insider filings on UFPT from the last six months, for Pro members.

All UFPT insider trades

UFPT trades by Congress and the executive branch

2 trades disclosed in the last six months. The newest:

SellDonald Trump$1K to $15KPresident (R)traded Jul 29, disclosed Sep 22(55 days later)
All 2 trades on UFPT disclosed by Congress and the executive branch, for Pro members.Get in free →See the top 3 →Start Pro

See what Congress is buying across the market

UFPT's officers and directors

Officers and directors with a Form 4 in the last 12 months.

4 more officers and directors file at UFPT.

See insider trades by person

Which ETFs hold UFPT?

In ETFs: UFPT is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About UFP Technologies

UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

5,349 employeesNewburyport, MAufpt.com

What UFP Technologies says it competes with

“The medical design and contract manufacturing industry is highly competitive as is the foam and plastics converting industry as a whole.”

From its annual report, SEC filing · Feb 27, 2026

Here is what Pro members see.

  • The same page for Pro members, on Microsoft

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on UFPT and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

  • What would turn UFPT's score around: 6 things
  • 2 more filings explained, a plain line each
  • Real-⁠time prices, no delay
BreakawayJul 1Donald Trump bought UFPT$15K to $50K, disclosed Jul 1

Alerts are optional.

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

Straight AnswersStraight Answers

As of Nov 21, 2026: UFPT's Quality Score is 5 (Below Average), #30 of 86 in Medical Devices. Insiders sold $12.9M in the last 6 months (Form 4).

What does UFPT's Quality Score say?

UFPT scores 5 today, which Breakaway calls Below Average. It is #30 of 86 in Medical Devices by Quality Score, with 2 of 14 chart checks firing. Up 18% on Nov 4, an up day for the market: the S&P 500 rose 2%, 72% of stocks rose, and medical device stocks a median 7%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is UFPT's Quality Score?

UFPT scores 5 today, which Breakaway calls Below Average (0 to 5). That is #30 of 86 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind UFPT's 5.

Are insiders buying UFPT?

5 insiders sold $12.9M across 15 filings in the last 6 months. No open-⁠market buys on record. The newest is Marc D. Kozin, Director, who sold $1.1M on Aug 25. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See all 3,170 stocks rankedSee all 3,170 stocks rankedStart Pro

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.